| Testosterone Replacement Therapy in Advanced Chronic Kidney Disease (NCT00645658) | Palo Alto Veterans Institute for Research | 2007-08-01 |
| Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected Patients (NCT00551655) | AIDS Arms Inc. | 2007-05-01 |
| Hemodilution and Outcome in Cardiac Surgery (NCT00364494) | Università Vita-Salute San Raffaele | 2006-11-01 |
| Dynepo Infrequent Dosing Study (NCT00450333) | Shire | 2006-10-30 |
| Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients (NCT00369382) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-09-01 |
| Study Evaluating Sirolimus in the Treatment of Kidney Transplant (NCT00282217) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-08-01 |
| Validation of Serum Creatinine Dosage and Renal Clearance (NCT00323128) | University Hospital, Ghent | 2006-05-01 |
| Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients (NCT00311311) | Pfizer | 2006-04-01 |
| Comparison of Bovine Carotid Artery and Expanded Polytetrafluoroethylene (ePTFE) for Permanent Hemodialysis Access (NCT01021839) | Massachusetts General Hospital | 2006-04-01 |
| Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients (NCT00294866) | Fresenius Medical Care North America | 2006-03-01 |
| COOL RCN: Cooling to Prevent Radiocontrast Nephropathy (NCT00306306) | Radiant Medical | 2006-03-01 |
| Vitamin Metabolism in Kidney Disease (NCT00257439) | Aalborg University Hospital | 2005-12-01 |
| CamTac Trial:Campath-Tacrolimus vs IL2R MoAb/Tacrolimus/MMF in Renal Transplantation (NCT00246129) | EMagnusson | 2005-10-01 |
| Hemodialysis Without Anticoagulation in Intensive Care Unit (NCT00242398) | Centre Hospitalier Départemental | 2005-10-01 |
| A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients (NCT00195429) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-08-01 |
| The Study of Infection and Cell Inflammation in Peritoneal Dialysate (NCT00173485) | National Taiwan University Hospital | 2005-06-01 |
| EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease) (NCT00211978) | Nabi Biopharmaceuticals | 2005-05-01 |
| PROMISS: Simvastatin Prevents the Contrast Induced Acute Renal Failure in Patients With Renal Insufficiency Undergoing Coronary Angiography (NCT00259441) | Seoul National University Hospital | 2005-02-01 |
| NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization (NCT00356954) | Seoul National University Hospital | 2005-02-01 |
| Study Evaluating Sirolimus in Kidney Transplant Recipients. (NCT00167947) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-01-01 |
| Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients (NCT00183248) | University of Miami | 2004-09-01 |
| Iron Sucrose in Stage 3/4 Kidney Disease (NCT00202345) | Melbourne Health | 2004-08-01 |
| Study Evaluating Sirolimus in Kidney Transplant Recipients in India (NCT00195481) | Wyeth is now a wholly owned subsidiary of Pfizer | 2004-04-01 |
| Correction of Anaemia and Progression of Renal Failure on Transplanted Patients (NCT00396435) | Centre Hospitalier Universitaire, Amiens | 2004-04-01 |
| Resistive Index Measurements After Kidney Transplantation (NCT01879124) | Universitaire Ziekenhuizen KU Leuven | 2004-03-01 |
| BIOBANK Renal Transplantation University Hospitals Leuven (NCT01331668) | Universitaire Ziekenhuizen KU Leuven | 2004-03-01 |
| Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus (NCT00195468) | Wyeth is now a wholly owned subsidiary of Pfizer | 2004-03-01 |
| Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant Recipients (NCT00266123) | Wyeth is now a wholly owned subsidiary of Pfizer | 2004-03-01 |
| Acetylcysteine in the Prevention of Renal Failure After Bypass Surgery (NCT00211653) | Minneapolis Veterans Affairs Medical Center | 2003-04-01 |
| Clopidogrel Prevention of Early Arteriovenous (AV) Fistula Thrombosis (NCT03289520) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2003-01-07 |
| AKIN Criteria: Acute Kidney Injury After On-Pump Coronary Artery Bypass Graft (CABG) (NCT00780845) | Hospital de Base | 2003-01-01 |
| Aggrenox Prevention of Access Stenosis (NCT00067119) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2003-01-01 |
| Study Evaluating Two Different Sirolimus-based Immunosuppressive Regimens in Elderly Kidney Transplant Recipients (NCT00254709) | Wyeth is now a wholly owned subsidiary of Pfizer | 2002-10-01 |
| The Effect of Isoflurane or Sevoflurane on Kidney Function (NCT00144118) | Austin Health | 2002-01-01 |
| Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients (NCT00273871) | Wyeth is now a wholly owned subsidiary of Pfizer | 2002-01-01 |
| Tc-99m Renography and Cisplatin-induced Nephrotoxicity (NCT00213642) | University Hospital, Rouen | 2001-07-01 |
| Sirolimus and Thymoglobulin to Prevent Kidney Transplant Rejection (NCT00006178) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2000-08-01 |
| Search for New Methods to Detect Acute Renal Failure (NCT00026702) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2000-06-07 |
| Stenting in Renal Dysfunction Caused by Atherosclerotic Renal Artery Stenosis (NCT00150943) | UMC Utrecht | 2000-06-01 |
| Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant Patients (NCT00213590) | University Hospital, Rouen | 2000-04-01 |
| Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis) (NCT00001959) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1999-12-01 |
| Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant (NCT00001859) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1999-06-04 |
| A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects. (NCT00364260) | Janssen-Ortho Inc., Canada | 1997-12-01 |
| Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure (NCT02194582) | Beth Israel Deaconess Medical Center | 1996-06-01 |
| Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients (NCT00261820) | Wyeth is now a wholly owned subsidiary of Pfizer | |
| Prospective Controlled Study of Posttransplant Diabetes (NCT00006331) | National Center for Research Resources (NCRR) | |
| Urinary Marker for Oxidative Stress in Human Cisplatin- Induced Renal Injury (NCT00310739) | Hamamatsu University | |